AU2021201921B2 - Polyunsaturated fatty acid triglyceride and preparation and uses thereof - Google Patents
Polyunsaturated fatty acid triglyceride and preparation and uses thereof Download PDFInfo
- Publication number
- AU2021201921B2 AU2021201921B2 AU2021201921A AU2021201921A AU2021201921B2 AU 2021201921 B2 AU2021201921 B2 AU 2021201921B2 AU 2021201921 A AU2021201921 A AU 2021201921A AU 2021201921 A AU2021201921 A AU 2021201921A AU 2021201921 B2 AU2021201921 B2 AU 2021201921B2
- Authority
- AU
- Australia
- Prior art keywords
- fatty acid
- lipase
- polyunsaturated fatty
- hydrolysis
- glycerin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 title claims abstract description 58
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title abstract description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 62
- 230000007062 hydrolysis Effects 0.000 claims abstract description 50
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 50
- 235000021588 free fatty acids Nutrition 0.000 claims abstract description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 34
- 235000011187 glycerol Nutrition 0.000 claims abstract description 31
- 238000000034 method Methods 0.000 claims abstract description 23
- 238000000199 molecular distillation Methods 0.000 claims abstract description 18
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 claims abstract description 16
- 230000032050 esterification Effects 0.000 claims abstract description 11
- 238000005886 esterification reaction Methods 0.000 claims abstract description 11
- 150000003839 salts Chemical class 0.000 claims abstract description 9
- 108090001060 Lipase Proteins 0.000 claims description 65
- 102000004882 Lipase Human genes 0.000 claims description 65
- 239000004367 Lipase Substances 0.000 claims description 65
- 235000019421 lipase Nutrition 0.000 claims description 65
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 30
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 24
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 24
- 229930195729 fatty acid Natural products 0.000 claims description 24
- 239000000194 fatty acid Substances 0.000 claims description 24
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 13
- 235000021342 arachidonic acid Nutrition 0.000 claims description 12
- 229940114079 arachidonic acid Drugs 0.000 claims description 12
- -1 fatty acid salt Chemical class 0.000 claims description 11
- 239000011541 reaction mixture Substances 0.000 claims description 10
- 241000195493 Cryptophyta Species 0.000 claims description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 7
- 150000004666 short chain fatty acids Chemical class 0.000 claims description 6
- 241000222175 Diutina rugosa Species 0.000 claims description 5
- 108010048733 Lipozyme Proteins 0.000 claims description 5
- FCCDDURTIIUXBY-UHFFFAOYSA-N lipoamide Chemical compound NC(=O)CCCCC1CCSS1 FCCDDURTIIUXBY-UHFFFAOYSA-N 0.000 claims description 5
- 108010084311 Novozyme 435 Proteins 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 241000228245 Aspergillus niger Species 0.000 claims description 3
- 241001507683 Penicillium aurantiogriseum Species 0.000 claims description 3
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 claims description 2
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 claims description 2
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 239000000126 substance Substances 0.000 abstract description 8
- 235000013305 food Nutrition 0.000 abstract description 6
- 235000013350 formula milk Nutrition 0.000 abstract description 4
- 235000013402 health food Nutrition 0.000 abstract description 4
- 229940127554 medical product Drugs 0.000 abstract description 4
- 230000003647 oxidation Effects 0.000 abstract description 3
- 238000007254 oxidation reaction Methods 0.000 abstract description 3
- 235000013376 functional food Nutrition 0.000 abstract description 2
- 239000003921 oil Substances 0.000 description 36
- 235000019198 oils Nutrition 0.000 description 36
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 22
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 22
- 239000000203 mixture Substances 0.000 description 14
- 238000004821 distillation Methods 0.000 description 12
- 150000004665 fatty acids Chemical class 0.000 description 12
- 229940090949 docosahexaenoic acid Drugs 0.000 description 11
- 229910052757 nitrogen Inorganic materials 0.000 description 11
- 238000003860 storage Methods 0.000 description 9
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 159000000000 sodium salts Chemical class 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 239000012299 nitrogen atmosphere Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 3
- 150000004667 medium chain fatty acids Chemical class 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 150000004671 saturated fatty acids Chemical class 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000907999 Mortierella alpina Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000010779 crude oil Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
- 235000021391 short chain fatty acids Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000598397 Schizochytrium sp. Species 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 125000005313 fatty acid group Chemical group 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6472—Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C1/00—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids
- C11C1/02—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids from fats or fatty oils
- C11C1/04—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids from fats or fatty oils by hydrolysis
- C11C1/045—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids from fats or fatty oils by hydrolysis using enzymes or microorganisms, living or dead
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C1/00—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids
- C11C1/08—Refining
- C11C1/10—Refining by distillation
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
- C11C3/10—Ester interchange
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/18—Lipids
- A23V2250/186—Fatty acids
- A23V2250/1882—Polyunsaturated fatty acids
Abstract
A method for preparing a polyunsaturated fatty acid triglyceride. (1) A raw oil is
mixed with water, homogenized and then subjected to lipase-catalyzed hydrolysis to
5 obtain a free fatty acid salt and glycerin. (2) The free fatty acid salt is separated from
the glycerin. (3) The free fatty acid salt is acidized to obtain a free fatty acid. (4) The
free fatty acid is dried and subjected to molecular distillation to obtain a long-chain
polyunsaturated fatty acid. (5) The long-chain polyunsaturated fatty acid is mixed
with glycerin and subjected to lipase-catalyzed esterification to obtain the
10 polyunsaturated fatty acid triglyceride. The polyunsaturated fatty acid triglyceride
prepared by this method has high purity with no chemical residue and less oxidation
loss. The disclosure also provides a polyunsaturated fatty acid triglyceride and uses
thereof in the preparation of infant formula foods, health food, functional foods or
medical products.
Description
This disclosure relates to microbial oil, and more particularly to a
polyunsaturated fatty acid triglyceride, and a preparation and uses thereof.
Polyunsaturated fatty acids carry at least two double bonds in their carbon chain,
and exhibit biological activities of stabilizing cell membrane, regulating gene
expression, maintaining cytokine and lipoprotein balance, reducing the risk of
cardiovascular diseases and promoting the growth and development. Polyunsaturated
fatty acids are dominated by n-3, n-6 and n-9 polyunsaturated fatty acids, where the
n-6 and n-3 polyunsaturated fatty acids are preferable due to their excellent biological
activities.
The polyunsaturated fatty acids are usually obtained by fish oil refining or
oleaginous microorganism-mediated fermentation. The polyunsaturated fatty acid
triglycerides are generally prepared by the fermentation, and usually contain medium
and low-purity polyunsaturated fatty acids, which are mainly used in the formula
foods for infant and the elder and health food. As for the medical product industry,
high-purity polyunsaturated fatty acids are preferred.
Currently, the high-purity polyunsaturated fatty acids are prepared mainly by
purifying the medium- and low-purity polyunsaturated fatty acids by means of
chromatography, distillation, solvent extraction, low-temperature crystallization,
supercritical extraction and urea inclusion. However, most of the products prepared by
this process are fatty acid ethyl esters, which are inferior to the fatty acid triglycerides
in terms of food safety and human absorption (the absorption rate of the fatty acid
ethyl esters is only about 20%).
Recently, a novel method for preparing high-purity polyunsaturated fatty acid
esters has been developed, in which medium- and low-purity polyunsaturated fatty acid esters are hydrolyzed into free fatty acids, from which the medium- and short-chain fatty acids are removed, and then the remaining fatty acids are re-esterified to produce the high-purity polyunsaturated fatty acid esters. However, the short-chain fatty acids are usually removed by reaction with short-chain alcohols, during which new chemicals are introduced, resulting in an increase in the production cost and a risk in food safety. Most of the lipases used in the hydrolysis processes of existing polyunsaturated fatty acid esters are specific enzymes that have different sensitivity to the ester bonds in different positions, leading to low hydrolysis speed and poor production efficiency. SUMMARY
A first aspect of the present disclosure provides a method for preparing a polyunsaturated fatty acid triglyceride. The preparation method desirably has high production efficiency and low oxidation loss, and the prepared polyunsaturated fatty acid triglyceride desirably has a high purity and is free of the solvent. A second aspect of the present disclosure provides a method of replacing saturated fatty acids in the triglyceride with polyunsaturated fatty acids to improve the content of the polyunsaturated fatty acids. The prepared polyunsaturated fatty acid triglyceride desirably has a high purity, and the polyunsaturated fatty acid thereof desirably has high biological activity and low safety risk. A third aspect of the present disclosure provides a use of the polyunsaturated fatty acid triglyceride in the preparation of formula foods for infant, health foods, functional foods or medical products. The aspects of the disclosure are specifically described as follows. In a first aspect, the present disclosure provides a method for preparing a polyunsaturated fatty acid triglyceride, comprising: (1) mixing a raw oil containing a polyunsaturated fatty acid with water followed by homogenizing at 45-65°C and 20-100 MPa and hydrolysis in the presence of a first lipase to obtain a free fatty acid salt and glycerin; (2) separating the free fatty acid salt obtained in step (1) from the glycerin to obtain the fatty acid salt;
(3) acidizing the free fatty acid salt obtained in step (2) to obtain a free fatty acid;
(4) drying the free fatty acid obtained in step (3); and subjecting the dried free
fatty acid to molecular distillation to remove a short-chain fatty acid to obtain a
long-chain polyunsaturated fatty acid; and
(5) mixing the long-chain polyunsaturated fatty acid obtained in step (4) with
glycerin followed by esterification in the presence of a second lipase to obtain the
polyunsaturated fatty acid triglyceride.
In some embodiments, in step (1), a weight ratio of the raw oil to the water is
1:(0.7-1.3); and/or the reaction mixture is adjusted to pH 6-7.5 with a 10-15%
aqueous sodium hydroxide solution or a 10-15% aqueous potassium hydroxide
solution to perform the hydrolysis in the presence of the first lipase. When the weight
ratio of the raw oil and the water is 1:(0.7-1.3), an oil-water contact area in an
emulsion formed by the homogenization is larger. The homogenization is performed
at 45-65°C and 20-100 MPa to allow the raw oil to be fully mixed with the water and
form a smaller particle size, increasing the oil-water contact area. The large oil-water
contact area helps the raw oils in better contact with a lipase to accelerate the
hydrolysis and improve the production efficiency. The pH of a hydrolysis system will
be gradually reduced due to the free fatty acid generated in the lipase-catalyzed
hydrolysis, and then will exceed a pH range in which the lipase has a relatively high
catalytic activity. Therefore, it is necessary to add an alkaline substance into the
hydrolysis system in real time to control the pH. In some embodiments, the hydrolysis
system is adjusted to pH 6-7.5 with a 10-15% aqueous sodium hydroxide solution or a
10-15% aqueous potassium hydroxide solution to maintain a catalytic activity of the
lipase. Moreover, the addition of a sodium hydroxide solution or a potassium
hydroxide solution can also make the free fatty acid released from the hydrolysis of
the raw oil into a sodium salt or a potassium salt, inhibiting the occurrence of a
reverse reaction of the hydrolysis.
In some embodiments, in step (1) and step (5), the first lipase and the second
lipase are independently a non-specific lipase selected from the group consisting of
Penicillium cyclopium (PG37 lipase), Candida rugosa lipase (CRL), Aspergillus niger lipase, Novozym 435, Lipozyme RM M, C.rugosa lipase, (CRL) and a combination thereof. In a preferred embodiment, the non-specific lipase can hydrolyze fatty acids in each position of the raw oil at the same time, overcoming the defect that the specific lipase can only hydrolyze the fatty acids in position 1 and position 3 of the raw oil and the fatty acids in position 2 have to be rearranged to position 1 or position
3 to be hydrolyzed, so as to accelerate the hydrolysis.
In some embodiments, in step (1), the hydrolysis is performed by adding an
immobilized first lipase to a reactor or by using packed beds carrying the immobilized
first lipase; and
in step (5), the esterification is performed by adding an immobilized second
lipase to a reactor or by using packed beds carrying the immobilized second lipase;
wherein the packed beds carrying the immobilized first lipase are connected in
series or parallel; and the packed beds carrying the immobilized second lipase are
connected in series or parallel.
The immobilized lipase is added into the hydrolysis kettle or made into packed
beds to perform the lipase-catalyzed hydrolysis. In this way, the lipase can be
immobilized at a position that is in full contact with a hydrolyzed substrate, increasing
a contact area between the lipase and the hydrolyzed substrate and accelerating the
hydrolysis. A loss of the lipase during the hydrolysis is reduced and a utilization rate
of the lipase is improved. The series or parallel packed bed reactors further expand the
contact area in the lipase-catalyzed hydrolysis and enhance the contact between the
lipase and the hydrolysis substrate, further accelerating the hydrolysis.
In some embodiments, in step (1), the first lipase is added in an amount of
100-500 U per gram of the raw oil; and the hydrolysis is performed at 35-65°C for
8-72 h. In a preferred embodiment, an addition amount of the lipase influences a
hydrolysis rate of the raw oil, but an increase in the addition amount of the lipase will
largely increase the production cost. A proper hydrolysis temperature can effectively
increase the hydrolysis rate of the lipase, and proper hydrolysis time can make the raw
oil fully hydrolyzed and improve the production efficiency. In step (5), the
esterification is performed at 35-55°C and 100-180 rpm for 30-50 h; the glycerin is
10-18% by weight of the long-chain polyunsaturated fatty acid; and the second lipase
is 5-20% by weight of the long-chain polyunsaturated fatty acid. In a preferred
embodiment, under an anhydrous environment, the lipase-catalyzed esterification is
better performed under the above reaction conditions.
In some embodiments, in step (4), the molecular distillation is performed at a
temperature of 120-185°C, a pressure of less than 0.5 Pa, a feed rate of 15-20 kg/h
and a film-wiping speed of 110-180 rpm. In a preferred embodiment, the pressure less
than 0.5 Pa reduces a boiling temperature of the free fatty acid, avoiding a thermal
decomposition of the free fatty acid. Meanwhile, the pressure also increases a mean
free path of vapor molecules, helping gas molecules reach a condensing surface for
condensing. The short and medium-chain fatty acids (a chain length of 12-20 carbon
atoms) will be gradually evaporated at 130-185°C and then condensed on the
condensing surface to be separated from the long-chain polyunsaturated fatty acid, so
that the obtained polyunsaturated fatty acid has a higher purity. The feed rate of 15-20
kg/hour and the film-wiping speed of 120-180 rpm allow the free fatty acid to form an
ultra-thin and turbulent liquid film, which is conducive to the increase of temperature
and the evaporation of the free fatty acid.
In some embodiments, steps (1)-(5) are all carried out under an oxygen-isolated
state. The oxygen-isolated state is achieved by vacuuming containers of raw materials,
intermediate substances and reaction products, or filling the containers with an inert
atmosphere such as nitrogen.
In some embodiments, the raw oil is a docosahexaenoic acid (DHA) algae oil, an
arachidonic acid (ARA) algae oil containing an or a combination thereof. DHA and
ARA exhibit strong biological activity, and have wide application range and great
market demand.
In a second aspect, the present disclosure provides a polyunsaturated fatty acid
triglyceride prepared by the method provide in the first aspect, comprising:
15% or less by weight of a monoglyceride;
10% or less by weight of a diglyceride; and
7 5% or more by weight of a triglyceride; wherein a weight percentage of a DHA triglyceride or an ARA triglyceride in the polyunsaturated fatty acid triglyceride is not less than 72%.
In a third aspect, the present disclosure provides a use of the polyunsaturated
fatty acid triglyceride in the preparation of infant formulas, health food, functional
foods or medical products.
Compared to the prior art, this application desirably has the following beneficial
effects.
1. Molecular distillation is employed herein to remove short- and medium-chain
fatty acids from the free fatty acid, so as to obtain a high-purity polyunsaturated fatty
acid. In the traditional separation methods, the short- and medium-chain fatty acids
are removed by esterification with a short-chain alcohol in an organic solvent,
resulting in a loss of the polyunsaturated fatty acid due to undesirable esterification
and organic solvent residue. By contrast, the method provided in this disclosure does
not require chemical solvents and additional chemicals, avoiding the loss of the
polyunsaturated fatty acid caused by esterification as well as a food-safety risk caused
by the residual organic solvent.
2. Before the hydrolysis, the raw oil is mixed with water and then homogenized
to form tiny particles in the water, facilitating the contact of the raw oil with water and
the lipase. Meanwhile, the steric hindrance brought by the distorted molecular
structure of the long-chain polyunsaturated fatty acid is overcome during the
hydrolysis, accelerating the lipase-catalyzed hydrolysis of the raw oil and improving
the reaction efficiency of the hydrolysis.
3. The lipase used herein is a non-specific lipase. The traditionally-used specific
lipase is only sensitive to the fatty acid groups in positions 1 and 3, and can only
directly catalyze the hydrolysis of the fatty acids in position 1 and position 3, and the
fatty acid in position 2 have to be rearranged to position 1 or 3 to be hydrolyzed,
slowing down the hydrolysis of the oil. The non-specific lipase can simultaneously
catalyze the hydrolysis of fatty acids in each position of the raw oil, accelerating the
hydrolysis and improving the reaction efficiency.
4. The preparation process is carried out in an oxygen-isolated environment, which prevents the oxidation of the polyunsaturated fatty acid during the reaction and storage process, and improves the quality of the polyunsaturated fatty acid triglyceride.
DETAILED DESCRIPTION OF EMBODIMENTS It should be noted that the range disclosed herein is not limited to the endpoints and values within the range, and are intended to include values close to the range. Any combination of numerical values made based on the range disclosed herein should be
considered as specifically disclosed in this disclosure.
Unless otherwise specified, the percentages used herein mean weight
percentages. The technical solutions of this disclosure will be described clearly with reference
to the embodiments. As used herein, the DHA algae oil is produced by Linyi Youkang Biology Co.,
Ltd (China) through the fermentation of Schizochytrium sp.; the ARA algae oil is
produced by Linyi Youkang Biology Co., Ltd (China) through the fermentation in the
presence of Mortierella alpine; the water is purified by reverse osmosis; the lipases are produced by Novozymes Inc. (China) or Hangzhou Verychem Science and
Technology Co., Ltd (China); the nitrogen has a purity of 99.99%, and is produced by
the JH-PN49-10 nitrogen generator manufactured by Guangzhou Zhongshan Jigao Science and Technology Co., Ltd (China); and the molecular distillation equipment is a DZ-80 three-stage short-path molecular distillation equipment manufactured by
Sichuan Jiuyuan Chemical Technology Co., Ltd. Unless otherwise specified, other
apparatuses are conventional chemical apparatuses; and reagents are commercially available analytical reagents. The component analysis is performed in accordance
with the national standard.
Example 1
(1) 100 kg of DHA refined oil (DHA: 43%) derived from algae oil was added into a reactor, to which 100 kg of water was added. The reaction mixture was homogenized at 55°C and 60 MPa for 10 min. Packed beds respective carrying immobilized Candida rugosa lipase in an amount of 200 U per gram of the oil and immobilized Crugosa lipase in an amount of 200 U per gram of the oil were connected in series. The homogenized product was filled into the series-connected packed bed, and adjusted to pH 4.8 with an aqueous sodium hydroxide solution. The reactor was vacuumed to a pressure of -0.09 MPa, and then introduced with nitrogen to a pressure of 0.05-0.09 MPa. Then the oil was hydrolyzed at 50°C for 45 h, and a 12% aqueous sodium hydroxide solution was automatically added after 4.5 h of the hydrolysis to maintain the hydrolysis system at a pH of 6.8-7. After the hydrolysis was completed, a mixture containing free fatty acid sodium salt and glycerin was obtained. (2) The mixture obtained in step (1) was transported into a temporary storage tank by nitrogen, and was filtered using a disc-type filter to recover the lipase and obtain a mixture of free fatty acid sodium salt and glycerin, which was allowed to stand for 4-6 h in the temporary storage tank under a nitrogen atmosphere. Then the glycerin and water were removed by separation, and a fatty acid sodium salt was collected.
(3) The fatty acid sodium salt obtained in step (2) was acidized with a 10%
sulfuric acid solution, and then subjected to standing for 2-3 h. The water was
removed, and a free fatty acid was obtained. (4) The free fatty acid obtained in step (3) was heated to 80-90°C, vacuumed to -0.09 MPa, dehydrated for 30-50 min and treated by a three-stage short-path
molecular distillation system, where parameters of the three-stage molecular
distillation system were shown in Table 1. Table 1 Parameters of molecular distillation in Example 1
Primary molecular Secondary molecular Tertiary molecular
distillation distillation distillation
Temperature of the 125-135 150-165 170-180 evaporator, °C
Temperature of the
condensing 50-65 65-75 75--85
surface, °C
Vacuum degree, Pa 0.3-0.4 0.3-0.1 0.1-0.06
Feeding speed, kg/h 16-18 16-18 16-18
Wiping speed, rpm 165 145 125
After the treatment using the three-stage short-path molecular distillation system,
a heavy phase was collected as a high-purity long-chain polyunsaturated fatty acid.
(5) 20 kg of the polyunsaturated fatty acid obtained in step (4) was esterified
with 2.8 kg of glycerin at 45°C and a stirring speed of 140 rpm in the presence of 3 kg of Novozym 435. After being reacted for 40 h, the reaction mixture was washed with
4 kg of 65°C water, and then subjected to standing for 2 h. The excess glycerin and water were removed to obtain a polyunsaturated fatty acid triglyceride.
Example 2
(1) 100 kg ofDHA crude oil (DHA: 45%) derived from an algae oil was added into a reactor, to which 70 kg of water was added. The reaction mixture was homogenized at 45°C and 20 MPa for 10 min. A packed bed was prepared using
immobilized Penicillium cyclopium lipase in an amount of 100 U per gram of the oil.
The homogenized product was filled into the packed bed, and adjusted to pH 4.8 with
an aqueous potassium hydroxide solution. The reactor was vacuumed to a pressure of -0.09 MPa, and then introduced with nitrogen to a pressure of 0.05-0.09 MPa. Then
the oil was hydrolyzed at 35°C for 72 h, and a 10% aqueous potassium hydroxide solution was automatically added after 4.5 h of the hydrolysis to maintain the
hydrolysis system at a pH of 6-6.5. After the hydrolysis was complete, a mixture
containing free fatty acid sodium salt and glycerin was obtained. (2) The mixture obtained in step (1) was transported into a temporary storage
tank by nitrogen, and was filtered using a disc-type filter to recover the lipase and obtain a mixture of free fatty acid potassium salt and glycerin, which was allowed to stand for 4-6 h in the temporary storage tank under a nitrogen atmosphere. Then the glycerin and water were removed by separation, and a fatty acid sodium salt was collected.
(3) The fatty acid sodium salt obtained in step (2) was acidized with a 10%
sulfuric acid solution, and then subjected to standing for 2-3 h. The water was removed, and a free fatty acid was obtained. (4) The free fatty acid obtained in step (3) was heated to 80-90°C, vacuumed to
-0.09 MPa, dehydrated for 30-50 min and treated by a three-stage short-path
molecular distillation system, where parameters of the three-stage molecular
distillation system were shown in Table 2. Table 2 Parameters of molecular distillation in Example 2
Primary molecular Secondary molecular Tertiary molecular
distillation distillation distillation
Temperature of the 120-128 130-155 160-170 evaporator, °C
Temperature of the
condensing 45-55 55-65 65--75
surface, °C
Vacuum degree, Pa 0.3-0.4 0.3-0.1 0.1-0.06
Feeding speed, kg/h 15-17 15-17 15-17
Wiping speed, rpm 155 135 110
After the treatment using the three-stage short-path molecular distillation system,
a heavy phase was collected as a high-purity long-chain polyunsaturated fatty acid
was obtained.
(5) 20 kg of the polyunsaturated fatty acid obtained in step (4) was esterified
with 2 kg of glycerin at 35°C and a stirring speed of 100 rpm in the presence of 1 kg
of Novozym 435. After being reacted for 50 h of the reaction, the reaction mixture was washed with 4 kg of 65°C water, and then subjected to standing for 2 h. The excess glycerin and water were removed to obtain a polyunsaturated fatty acid triglyceride.
Example 3 100 kg of ARA crude oil (ARA: 46%) derived from Mortierella alpine was added into a reactor, to which 130 kg of water was added. The reaction mixture was homogenized at 65°C and 100 MPa for 10 min. Aspergillus niger lipase in an amount
of 500 U per gram of the oil was added into the reactor. An aqueous sodium hydroxide
solution was added to adjust the mixture to pH 4.8. The reactor was vacuumed to a
pressure of -0.09 MPa, and then introduced with nitrogen to adjust a pressure of 0.05-0.09 MPa. Then the oil was hydrolyzed at 65°C for 8 h, and a 15% aqueous
sodium hydroxide solution was automatically added after 4.5 h of the hydrolysis to maintain the hydrolysis system at a pH of 7-7.5. After the hydrolysis was completed, a
mixture containing free fatty acid sodium salt and glycerin was obtained.
(2) The mixture obtained in step (1) was transported into a temporary storage tank by nitrogen, and was filtered using a disc-type filter to recover the lipase and
obtain a mixture of free fatty acid sodium salt and glycerin, which was allowed to
stood for 4-6 h in the temporary storage tank under a nitrogen atmosphere. Then the
glycerin and water were removed by separation, and a fatty acid sodium salt was collected. (3) The fatty acid sodium salt obtained in step (2) was acidized with a 10%
sulfuric acid solution, and then subjected to standing for 2-3 h. The water was
removed, and a free fatty acid was obtained. (4) The free fatty acid obtained in step (3) was heated to 80-90°C, vacuumed to
-0.09 MPa, dehydrated for 30-50 min and treated by a three-stage short-path
molecular distillation system, where working parameters of the three-stage molecular distillation system were shown in Table 3.
Table 3 Parameters of molecular distillation in Example 3
Primary molecular Secondary molecular Tertiary molecular
distillation distillation distillation
Temperature of the 130-140 155-170 175-185 evaporator, °C
Temperature of the
condensing 50-65 65-75 75--85
surface, °C
Vacuum degree, Pa 0.3-0.4 0.3-0.1 0.1-0.06
Feeding speed, kg/h 18-20 18-20 18-20
Wiping speed, rpm 180 160 135
After the treatment using the three-stage short-path molecular distillation system,
a heavy phase was collected as a high-purity long-chain polyunsaturated fatty acid
was obtained.
(5) 20 kg of the polyunsaturated fatty acid obtained in step (4) was esterified
with 3.6 kg of glycerin at 55°C and a stirring speed of 180 rpm in the presence of 4 kg
of Lipozyme RM M. After being reacted for 30 h, the reaction mixture was washed
with 4 kg of 65°C water, and then subjected to standing for 2 h. The excess glycerin
and water were removed to obtain a polyunsaturated fatty acid triglyceride.
Comparative Example
(1) 100 kg of DHA refined oil (DHA: 43%) derived from an algae oil was added into a reactor, to which 100 kg of water was added. The reaction mixture was
homogenized at 55°C and 60 MPa for 10 min. A specific enzyme, Lipozyme RM M
(RML), was added into the reactor in an amount of 200 U per gram of the oil. An
aqueous sodium hydroxide solution was added to adjust the mixture to pH 4.8. The
reactor was vacuumed to a pressure of -0.09 MPa, and then introduced with nitrogen
to a pressure of 0.05-0.09 MPa. Then the oil was hydrolyzed at 50°C for 82 h, and a
12% aqueous sodium hydroxide solution was automatically added during the hydrolysis to maintain the hydrolysis system at a pH of 6.8-7. After the hydrolysis was completed, a mixture containing free fatty acid sodium salt and glycerin was obtained.
(2) The mixture obtained in step (1) was transported into a temporary storage
tank by nitrogen, and was filtered using a disc-type filter to recover the lipase and
obtain a mixture of free fatty acid sodium salt and glycerin, which was allowed to stand for 4-6 h in the temporary storage tank under a nitrogen atmosphere. Then the glycerin and water were removed by separation, and a fatty acid sodium salt was
collected.
(3) The fatty acid sodium salt obtained in step (2) was acidized with a 10%
sulfuric acid solution, and then subjected to standing for 2-3 h. The water was removed, and a free fatty acid was obtained.
(4) The free fatty acid obtained in step (3) was heated to 80-90°C, vacuumed to -0.09 MPa, and then dehydrated for 30-50 min. The temperature was slowly lowered
according to the parameters shown in Table 4, and the free fatty acid was winterized
to make a saturated fatty acid crystallize out. The crystallized saturated fatty acid was removed using a plate-frame filter press, and a polyunsaturated fatty acid was
obtained.
Table 4 Winterization parameters of free fatty acid
Rotation speed Cooling Holding time Step Temperature (°C) Time (min) (Hz) amplitude (h)
1 70 30 15 0 0.5
2 60 30 15 10 0.5
3 50 30 15 10 0.5
4 44 60 15 6 1
5 41 60 15 3 1
6 38 60 15 3 1
7 35 60 15 3 1
8 32 90 15 3 1.5
9 28 90 15 3 1.5
10 25 60 15 3 1
11 21 120 15 4 2
12 19 60 15 2 1
13 17 60 15 2 1
14 16 60 15 1 1
15 15 60 15 1 1
16 14 60 15 1 1
17 13 60 15 1 1
18 12.8 60 15 0.2 1
19 12.6 60 15 0.2 1
20 13 60 15 -0.4 1
21 14 60 15 -1 1
22 12 60 15 2 1
23 10 60 15 2 1
24 8 60 15 2 1
25 6 60 15 2 1
26 6 60 15 0 20
After the winterization, a filtrate was collected, so as to obtain a high-purity
long-chain polyunsaturated fatty acid.
(5) 20 kg of the polyunsaturated fatty acid obtained in step (4) was esterified
with 2.3 kg of glycerin at 45°C and a stirring speed of 140 rpm in a presence of 3.5 kg
of Lipozyme RM IM. After being reacted for 40 h, the reaction mixture was washed
with 4 kg of 65°C water, and then subjected to standing for 2 h. The excess glycerin
and water were removed to obtain a polyunsaturated fatty acid triglyceride.
Contents of DHA or ARA, monoglyceride, diglyceride and triglyceride in the
polyunsaturated fatty acid triglyceride in each example were measured and shown in
Table 5.
Table 5 Polyunsaturated fatty acid components in Examples and Comparative
Example
DHA/ARA Monoglyceride Example number Diglyceride (%) Triglyceride (%) (0) (0)
Example 1 87.1 8.5 6.2 85.3
Example 2 85.8 11.3 6.6 82.1
Example 3 84.3 14.3 6.9 78.8
Comparative 62.3 17.9 11.3 70.8 example
Table 5 showed that the content of DHA/ARA in the polyunsaturated fatty acid
triglycerides obtained in Examples 1-3 using the method of disclosure were
significantly higher than that obtained using the method of the comparative example.
Moreover, compared with the comparative example, the polyunsaturated fatty acid
obtained in Examples 1-3 had a higher proportion of the polyunsaturated fatty acid
triglyceride, and a lower proportion of the polyunsaturated fatty acid monoglyceride
or the polyunsaturated fatty acid diglyceride. Meanwhile, the method using in
Examples 1-3 has a shorter production time and a higher efficiency. The method for
preparing a polyunsaturated fatty acid triglyceride provided herein is more beneficial.
The obtained polyunsaturated fatty acid triglyceride has a higher purity
polyunsaturated fatty acid, and has higher medicinal and edible value.
The above-mentioned embodiments are only preferred embodiments, and not
intend to limit the scope of the disclosure. It should be noted that various variations
and modifications made by those skilled in the art without departing from the spirit of
the invention should fall within the scope of the disclosure defined by the appended
claims.
The reference to any prior art in this specification is not, and should not be taken
as, an acknowledgement or any form of suggestion that such prior art forms part of
the common general knowledge.
It will be understood that the terms "comprise" and "include" and any of their
derivatives (e.g. comprises, comprising, includes, including) as used in this specification, and the claims that follow, is to be taken to be inclusive of features to which the term refers, and is not meant to exclude the presence of any additional features unless otherwise stated or implied.
Claims (8)
1. A method for preparing a polyunsaturated fatty acid triglyceride, comprising:
(1) mixing a raw oil containing a polyunsaturated fatty acid with water followed
by homogenizing at 45-65°C and 20-100 MPa and hydrolysis in the presence of a first
lipase to obtain a free fatty acid salt and glycerin;
(2) separating the free fatty acid salt obtained in step (1) from the glycerin to
obtain the fatty acid salt;
(3) acidizing the free fatty acid salt obtained in step (2) to obtain a free fatty acid;
(4) drying the free fatty acid obtained in step (3); and subjecting the dried free
fatty acid to molecular distillation to remove a short-chain fatty acid to obtain a
long-chain polyunsaturated fatty acid; and
(5) mixing the long-chain polyunsaturated fatty acid obtained in step (4) with
glycerin followed by esterification in the presence of a second lipase to obtain the
polyunsaturated fatty acid triglyceride.
2. The method according to claim 1, wherein in step (1), a weight ratio of the raw
oil to the water is 1:(0.7-1.3); and/or
the reaction mixture is adjusted to pH 6-7.5 with a 10-15% aqueous sodium
hydroxide solution or a 10-15% aqueous potassium hydroxide solution to perform the
hydrolysis in the presence of the first lipase.
3. The method according to claim 1 or 2, wherein the first lipase and the second
lipase are independently a non-specific lipase selected from the group consisting of
Penicillium cyclopium lipase, Candida rugosa lipase, Aspergillus niger lipase,
Novozym 435, Lipozyme RM M, C.rugosa lipase and a combination thereof.
4. The method according to any one of claims 1-3, wherein in step (1), the
hydrolysis is performed by adding an immobilized first lipase to a reactor or by using
packed beds carrying the immobilized first lipase; and in step (5), the esterification is performed by adding an immobilized second lipase to a reactor or by using packed beds carrying the immobilized second lipase; wherein the packed beds carrying the immobilized first lipase are connected in series or parallel; and the packed beds carrying the immobilized second lipase are connected in series or parallel.
5. The method according to any one of claims 1-4, wherein in step (1), the first lipase is added in an amount of 100-500 U per gram of the raw oil; and the hydrolysis is performed at 35-65°C for 8-72 h; and in step (5), the esterification is performed at 35-55°C and 100-180 rpm for 30-50 h; the glycerin is 10-18% by weight of the long-chain polyunsaturated fatty acid; and the second lipase is 5-20% by weight of the long-chain polyunsaturated fatty acid.
6. The method according to any one of claims 1-5, wherein in step (4), the molecular distillation is performed at a temperature of 120-185°C, a pressure of less than 0.5 Pa, a feed rate of 15-20 kg/h and a film-wiping speed of 110-180 rpm.
7. The method according to any one of claims 1-6, wherein steps (1)-(5) are all carried out under an oxygen-isolated state.
8. The method according to any one of claims 1-7, wherein the raw oil is a docosahexaenoic acid (DHA) algae oil, an arachidonic acid (ARA) algae oil containing an or a combination thereof.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010245559.6A CN111560403A (en) | 2020-03-31 | 2020-03-31 | Triglyceride type polyunsaturated fatty acid and preparation method and application thereof |
CN202010245559.6 | 2020-03-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2021201921A1 AU2021201921A1 (en) | 2021-10-14 |
AU2021201921B2 true AU2021201921B2 (en) | 2022-08-04 |
Family
ID=72067688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2021201921A Active AU2021201921B2 (en) | 2020-03-31 | 2021-03-26 | Polyunsaturated fatty acid triglyceride and preparation and uses thereof |
Country Status (4)
Country | Link |
---|---|
KR (1) | KR20210122095A (en) |
CN (1) | CN111560403A (en) |
AU (1) | AU2021201921B2 (en) |
WO (1) | WO2021196881A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111560403A (en) * | 2020-03-31 | 2020-08-21 | 瞿瀚鹏 | Triglyceride type polyunsaturated fatty acid and preparation method and application thereof |
CN112266940A (en) * | 2020-11-07 | 2021-01-26 | 润科生物工程(福建)有限公司 | Production process of grease with high DHA (docosahexaenoic acid) content in mono-glyceride and diglyceride |
CN114164048A (en) * | 2021-12-06 | 2022-03-11 | 润科生物工程(福建)有限公司 | Preparation method of high-content DHA grease |
CN116042736A (en) * | 2023-02-24 | 2023-05-02 | 江南大学 | Enzymatic production process of diglyceride |
CN116218922A (en) * | 2023-02-24 | 2023-06-06 | 江南大学 | Enzymatic preparation method of diglyceride oil |
CN116179622A (en) * | 2023-02-24 | 2023-05-30 | 江南大学 | Method for preparing n-3polyunsaturated fatty acid diglyceride by enzyme method |
CN116445558A (en) * | 2023-02-24 | 2023-07-18 | 江南大学 | Preparation method of diglyceride oil |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110004188A (en) * | 2019-03-30 | 2019-07-12 | 湖南万全裕湘生物科技有限公司 | A method of preparing PUFAs glyceride from the crude oil that microbial fermentation obtains |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101348807B (en) * | 2008-08-26 | 2011-07-27 | 江南大学 | Method for enrichment of n-3 polyunsaturated fatty acid glyceride from fish oil |
CN111560403A (en) * | 2020-03-31 | 2020-08-21 | 瞿瀚鹏 | Triglyceride type polyunsaturated fatty acid and preparation method and application thereof |
-
2020
- 2020-03-31 CN CN202010245559.6A patent/CN111560403A/en not_active Withdrawn
-
2021
- 2021-02-03 WO PCT/CN2021/075077 patent/WO2021196881A1/en active Application Filing
- 2021-03-15 KR KR1020210033212A patent/KR20210122095A/en not_active Application Discontinuation
- 2021-03-26 AU AU2021201921A patent/AU2021201921B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110004188A (en) * | 2019-03-30 | 2019-07-12 | 湖南万全裕湘生物科技有限公司 | A method of preparing PUFAs glyceride from the crude oil that microbial fermentation obtains |
Also Published As
Publication number | Publication date |
---|---|
AU2021201921A1 (en) | 2021-10-14 |
WO2021196881A1 (en) | 2021-10-07 |
KR20210122095A (en) | 2021-10-08 |
CN111560403A (en) | 2020-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2021201921B2 (en) | Polyunsaturated fatty acid triglyceride and preparation and uses thereof | |
CN105821088A (en) | Method for preparing glyceride rich in EPA and DHA through enzyme catalysis | |
US20220282290A1 (en) | Method for Synthesizing Diglyceride | |
CN110951796B (en) | Method for converting fatty acid ethyl ester into diglyceride | |
CN111088296B (en) | Method for enriching n-3 polyunsaturated fatty acid glyceride in grease | |
CN106566658A (en) | Enzymatic deacidifying method for high-acid-value oil | |
EP1582594A2 (en) | Improved enzymatic process for the preparation of polyunsaturated fatty acid triglycerides | |
CN112322670A (en) | Method for synthesizing diglyceride | |
CN102268464A (en) | Method for producing diglyceride with rice bran oil of high acid value | |
CN111172209B (en) | Method for preparing monoglyceride type n-3PUFA by enzyme method | |
US10870869B2 (en) | Enzymatic method for preparing glyceryl butyrate | |
JP3072022B2 (en) | Diglyceride production method | |
CN112841313A (en) | Preparation method of oil rich in OPL and OPO and product thereof | |
EP1582595A1 (en) | Enzymatic process for the preparation of triglycerides on the basis of polyunsaturated fatty acid esters | |
CN113832200B (en) | Preparation method of breast milk structured fat | |
CN113337551B (en) | Preparation method of structural triglyceride | |
CN111996218B (en) | Method for preparing diglyceride by enzyme method | |
US11396667B2 (en) | Enzymatic method for preparation of lecithin polyunsaturated fatty acids (PUFAs) | |
CN114480518A (en) | Method for preparing medium-long carbon chain triglyceride by enzyme method | |
CN113957104A (en) | Method for preparing diglyceride by enzyme method | |
CN112980898A (en) | Method for concentrating DHA in schizochytrium limacinum grease | |
CN111892992A (en) | Method for preparing diglyceride by chemical catalysis | |
JP3510422B2 (en) | Method for producing glycerin fatty acid ester | |
CN113481249B (en) | Method for preparing lecithin type n-3PUFA by enzyme method | |
CN113481247B (en) | Preparation method of medium-carbon-chain triglyceride |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |